Home▸Osteoporosis Pathophysiology & Therapy▸Atypical Femur Fracture & Osteonecrosis of Jaw Risk Simulator

🦴 Atypical Femur Fracture & Osteonecrosis of Jaw Risk Simulator

The model simulates the risk of atypical femur fractures and osteonecrosis of the jaw associated with long-term anti-resorptive therapy, depending on the duration of treatment.

Osteoporosis Pathophysiology & Therapy2DModerate60 FPS
atypical-femur-fracture-onj-risk-simulator ↗ Open standalone

Normal Bone Remodeling Turnover

Bone remodeling units couple resorption and formation to renew skeletal tissue.

  • ~4 mo: Remodeling cycle length (per BMU cycle)
  • ~3%/yr: Cortical bone turnover (annual replacement)
  • ~25%/yr: Trabecular bone turnover (annual replacement)
  • ~1M: Active BMUs (adult skeleton) (at any given time)

The basic multicellular unit (BMU)

Osteoclasts resorb old bone, then osteoblasts refill the cavity.

Coupling of resorption and formation

Coupling signals keep formation matched to resorption volume.

Why turnover matters

Turnover clears fatigue damage before it can propagate.

Long-Term Antiresorptive Therapy Begins

Bisphosphonates and denosumab suppress osteoclast activity to reduce fracture risk.

  • Years: Typical bisphosphonate half-life (bound in bone matrix)
  • ~50%: Vertebral fracture reduction (with standard therapy)
  • 3–5 yr: Common duration threshold (before drug holiday review)
  • 6 mo: Denosumab dosing interval (subcutaneous injection)

Mechanism of osteoclast suppression

Drugs inhibit osteoclast recruitment, activity, and survival.

Intended therapeutic benefit

Reduced turnover raises bone mineral density and strength.

The duration trade-off

Longer suppression trades common fractures for rare ones.

Micro-Damage Accumulates Unrepaired in the Femoral Cortex

Suppressed remodeling leaves microscopic fatigue cracks unrepaired over time.

  • ↑ with duration: Microcrack density vs control (suppressed cortex)
  • Targeted remodeling: Crack repair pathway (impaired under suppression)
  • Lateral cortex: Affected region (subtrochanteric femur)
  • >3–5 yr: Typical onset (cumulative exposure)

Targeted vs stochastic remodeling

Targeted repair of microcracks is the first casualty of suppression.

Matrix hypermineralization

Older, more brittle bone matrix accumulates without turnover.

Beak sign formation

Lateral cortical thickening forms before visible fracture.

Atypical Subtrochanteric Fracture Risk Rises With Duration

Cumulative micro-damage culminates in a low-energy transverse cortical fracture.

  • Subtrochanteric: Fracture location (/ diaphyseal femur)
  • Transverse: Fracture pattern (minimal comminution)
  • Rises sharply: Risk vs duration (beyond 5–8 years)
  • Common: Bilateral involvement (contralateral warning signs)

Radiographic hallmark features

Lateral cortical beaking precedes the completed fracture line.

Prodromal thigh pain

Dull thigh pain often warns weeks before fracture.

Duration-dependent risk curve

Risk climbs nonlinearly the longer suppression continues.

Dental Extraction Meets Suppressed Jaw Remodeling

High jaw turnover normally heals extraction sockets quickly and completely.

  • ~10× higher: Jaw bone turnover vs femur (baseline remodeling rate)
  • 8 wk: ONJ definition threshold (exposed bone, non-healing)
  • Most common: Extraction as trigger (precipitating event)
  • Higher: Risk with IV antiresorptives (than oral formulations)

Why the jaw is uniquely vulnerable

High turnover plus oral bacteria create a healing-dependent niche.

Extraction as the precipitating event

Extraction sockets need active remodeling to close over.

Prevention and management

Drug holidays and dental clearance lower procedural risk.

⚙ Under the hood

The model simulates the risk of atypical femur fractures and osteonecrosis of the jaw associated with long-term anti-resorptive therapy, depending on the duration of treatment.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)